Paramyxoviridae infectious disease
Paramyxoviridae infectious disease
Explore linked clinical trials. Standard reference: MONDO:000589665 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of BLB-201 RSV Vaccine in Infants and Children | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT05655182 | |
| Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, autoimmune disease, immune system disorder, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 2 | 2026-10-01 | NCT06817889 | |
| An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-10-01 | NCT06534892 | |
| A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 2 | 2026-09-29 | NCT07214571 | |
| A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-28 | NCT07092865 | |
| Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-09-28 | NCT04732871 | |
| Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Not yet recruiting | Not stated | 2026-09-24 | NCT07235397 | |
| Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, parotid disorder, parotitis, rubella, salivary gland disorder, viral infectious disease | Recruiting | Phase 4 | 2026-09-24 | NCT07195032 | |
| A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 3 | 2026-09-24 | NCT06866405 | |
| The EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Not yet recruiting | Phase 4 | 2026-09-17 | NCT07824167 | |
| RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults | COVID-19, Coronaviridae Infections, Cytopenia, Hemic and Lymphatic Diseases, Infections, Mononegavirales infectious disease, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, agranulocytosis, hematologic disorder, immune system disorder, inborn error of immunity, influenza, leukocyte disorder, leukopenia, lung disorder, lymphopenia, neutropenia, pneumonia, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-09-11 | NCT07816471 | |
| Internal Jugular Vein Respiratory Variability as a Marker of Disease Severity in Infant Bronchiolitis | Bronchiolitis, Viral, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, acute bronchiolitis, bronchial disorder, bronchiolitis, bronchitis, lung disorder, obstructive lung disease, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Not yet recruiting | Not stated | 2026-08-21 | NCT07778225 | |
| Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV in Children Under 6 Months in Bogotá | Bronchiolitis, Viral, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, bronchial disorder, bronchiolitis, bronchitis, lung disorder, obstructive lung disease, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral respiratory tract infection | Active, not recruiting | Not stated | 2026-08-06 | NCT07279298 | |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, Varicella Zoster Virus Infection, chickenpox, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, parotid disorder, parotitis, rubella, salivary gland disorder, viral infectious disease | Not yet recruiting | Phase 3 | 2026-08-03 | NCT07742644 | |
| Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France | COVID-19, Coronaviridae Infections, Infections, Mononegavirales infectious disease, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, influenza, lung disorder, pneumonia, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-08-03 | NCT07599449 | |
| A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-08-03 | NCT07220109 | |
| A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 2 | 2026-07-20 | NCT07482657 | |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, Varicella Zoster Virus Infection, chickenpox, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, parotid disorder, parotitis, rubella, salivary gland disorder, viral infectious disease | Recruiting | Phase 3 | 2026-07-08 | NCT07406360 | |
| Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 3 | 2026-07-01 | NCT06363370 | |
| Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study | COVID-19, Coronaviridae Infections, Infections, Mononegavirales infectious disease, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Parainfluenza, Paramyxoviridae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-06-23 | NCT03808922 | |
| A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection. | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, cardiovascular disorder, heart disorder, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2026-06-22 | NCT07658534 | |
| Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections | COVID-19, Coronaviridae Infections, Infections, Mononegavirales infectious disease, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, influenza, lung disorder, pneumonia, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Not stated | 2026-06-11 | NCT07643688 | |
| Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) | COVID-19, Coronaviridae Infections, Infections, Inflammation, Mononegavirales infectious disease, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Paramyxoviridae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumovirus Infections, RNA Virus Infections, Respiration Disorders, Shock, Systemic Inflammatory Response Syndrome, adult acute respiratory distress syndrome, cytokine release syndrome, influenza, lung disorder, pneumonia, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 1 / Phase 2 | 2026-06-10 | NCT06684379 | |
| Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older. | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-05-27 | NCT07582796 | |
| Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults | Human MetapneumoVirus Infection, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-20 | NCT06984094 |